News

Nov 11, 2018
Results of a new study showed that AFP categories agreed moderately with mRECIST outcomes and yielded accurate prognostic prediction in patients with unresectable hepatocellular carcinoma and AFP levels ≥400 ng/mL treated with chemoembolization. | Read More
Nov 07, 2018
A concentrated dose of anti-CEA CAR-T cells administered precisely at the site of a solid tumor by Pressure-enabled Drug Delivery (PEDD) is safe, with encouraging clinical responses, according to the results of a phase 1b clinical trial. | Read More
Nov 04, 2018
In patients with ultrasound-invisible early stage hepatocellular carcinoma, the combined therapy of conventional transarterial chemoembolization followed by fluoroscopy-guided radiofrequency ablation was safe and effective resulting in less local tumor progression and time to progression. | Read More
Oct 30, 2018
A nomogram including 6 pre-Y90 radioembolization (RAE) parameters predicted overall survival (OS) post-RAE in patients with colorectal cancer liver metastases. | Read More
Oct 28, 2018
For the treatment of patients with unresectable hepatocellular carcinoma, the combination of TACE with iodine [131I] metuximab infusion may improve local efficacy and overall survival when compared with TACE alone. | Read More
Oct 21, 2018
A new study sought to determine if patient and facility demographics impacted overall survival in patients with early-stage non-small cell lung cancer treated with radiofrequency ablation. | Read More
Oct 14, 2018
Computed tomography-guided percutaneous microwave ablation is safe and well-tolerated in patients with renal cell carcinoma and achieves nephron preservation similar to existing ablative modalities. | Read More
Oct 14, 2018
A new study found that Y90 radioembolization with glass microspheres given at a boosted dose in patients with large hepatocellular carcinomas (HCCs) may show favorable tumor response. | Read More
Oct 03, 2018
Percutaneous image-guided core needle biopsies in tumor >2 cm are safe and effective in obtaining tumour genetic material, according to a study published in the European Journal of Cancer. | Read More
Sep 30, 2018
A new study that looked at outcomes of surgical resection after yttrium-90 (Y90) transarterial radioembolization (TARE) in patients with hepatocellular carcinoma found that TARE can serve as a safe bridge to resection. | Read More